Jesús
San Miguel Izquierdo
Consultor Investigador
Centre hospitalier Lyon Sud
Pierre-Bénite, FranciaPublikationen in Zusammenarbeit mit Forschern von Centre hospitalier Lyon Sud (1)
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458